Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amarin USD -7332000 8.44M 2023-09
Amgen USD 3.66B 713M 2023-12
Baxter International USD 780M 31M 2023-12
Cara Therapeutics USD -28839000 3.44M 2023-09
Cytokinetics USD -121083000 672K 2023-12
Eli Lilly USD 3.84B 1.88B 2023-09
Esperion Therapeutics USD -27507000 9.5M 2023-09
Halozyme Therapeutics USD 121.73M 10.37M 2023-12
Intra Cellular Therapies USD -33961000 4.38M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
MannKind USD 11.98M 7.82M 2023-12
Minerva Neurosciences USD -6071000 1.56M 2023-09
Nektar Therapeutics USD -31809000 70K 2023-09
Peregrine Pharmaceuticals USD -8368000 8.86M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Rigel Pharmaceuticals USD -4173000 798K 2023-09
United Therapeutics USD 277.4M 62.9M 2023-12
Vanda Pharmaceuticals USD -2489000 5.16M 2023-06



Halozyme Therapeutics - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.